Pharmacologic and pharmacokinetic properties of methocarbamol in the horse.
The hemodynamic, respiratory, and behavioral effects, as well as the pharmacokinetic properties of methocarbamol, were determined in horses. Heart rate, cardiac output, arterial and venous blood pressures, respiratory rate, and arterial blood gases did not change after IV methocarbamol (4.4, 8.8, 17.6 mg/kg) administration. There were no signs of behavior modification or ataxia observed. Analysis of plasma concentration time data indicated that the disposition of methocarbamol may be dose-dependent. Clearance and steady-state volume of distribution decreased as the dose increased. Plasma concentrations of guaifenesin, a metabolite of methocarbamol, were never greater than 0.5% of the plasma concentration of methocarbamol.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D001784:Blood Gas Analysis / Q000662:veterinary; D002851:Chromatography, High Pressure Liquid; D005260:Female; D006207:Half-Life; D006439:Hemodynamics / Q000187:drug effects*; D006736:Horses / Q000097:blood / Q000502:physiology*; D007700:Kinetics; D008297:Male; D008721:Methocarbamol / Q000097:blood / Q000494:pharmacology*; D012119:Respiration / Q000187:drug effects*
D008721:Methocarbamol